Company Filing History:
2 out of 310 
1 out of 10 Years Active: 1993-1996
Title: Innovator Nigel Yarlett: Pioneering Advancements in Therapeutic Compounds
Introduction
Nigel Yarlett, an accomplished inventor based in Elmhurst, NY, has made significant contributions to the field of medicinal chemistry. He is recognized for his innovative work in developing compounds that target pathogenic microorganisms and neoplastic diseases, showcasing a commitment to advancing healthcare.
Latest Patents
Yarlett holds two notable patents that highlight his groundbreaking research on 5'-deoxy-5'-(substituted)alkylthioribose compounds. These include the following compounds: 5'-deoxy-5'-(hydroxyethylthio)adenosine (HETA), 5'-deoxy-5'-(monofluoroethylthio)adenosine (MFETA), 5'-deoxy-5'-(chloroethylthio)adenosine (CETA), and 5'-deoxy-5'-(bromoethylthio)adenosine (BETA). Additionally, he has developed variants such as 5-deoxy-5-(monofluoroethylthio)ribose (MFETR), 5-deoxy-5-(chloroethylthio)ribose (CETR), 5-deoxy-5-(bromoethylthio)ribose (BETR), and 5-deoxy-5-(hydroxyethylthio)ribose (HETR). These compounds demonstrate potential uses in treating infections caused by pathogenic microorganisms that possess 5'-deoxy-5'-methylthioadenosine (MTA) phosphorylase and 5-deoxy-5-methylthioribose (MTR) kinase, along with providing therapeutic options for neoplastic diseases.
Career Highlights
Throughout his career, Yarlett has been affiliated with prominent organizations such as Health Research, Inc. and Pace University. His work within these institutions has allowed him to advance his research and collaborate with various experts in the field.
Collaborations
Yarlett has worked alongside notable coworkers Janice R. Sufrin and Cyrus J. Bacchi. Their collaboration has been instrumental in refining and implementing solutions based on the innovative compounds he has developed.
Conclusion
Nigel Yarlett is a distinguished inventor whose contributions to the field of therapeutic compounds are paving the way for new treatment options against pathogenic infections and neoplastic diseases. His ongoing dedication to research and collaboration significantly impacts the medical community, highlighting the transformative potential of innovative inventions in healthcare.